Home › Brands › AYR Wellness
⚐ Flag an error How this page was made
Also known as: Ayr Strategies · AYR Inc. · AYRWF

AYR Wellness

Publicly traded US cannabis operator with retail and cultivation across multiple states.

Automated fact-check pass
6 cited sources
Published
Last reviewed
How this page was made
↯ The honest take

AYR Wellness is a real, licensed multi-state cannabis operator with products in legal markets. It trades publicly but faces common MSO headwinds: debt, flat wholesale prices, and federal illegality blocking major-exchange listing. Don't confuse AYR's 'Lazarus' cannabis brand with the unrelated 'Lazarus Naturals' hemp-CBD company. Check COAs, current licensing, and recent restructuring news before relying on brand claims.

What it is

AYR Wellness Inc. is a vertically integrated cannabis company operating cultivation facilities, manufacturing sites, and retail dispensaries across multiple US state-legal markets. The company is publicly traded on the Canadian Securities Exchange under the symbol AYR.A and on US OTC markets as AYRWF [1][2]. Its headquarters are in Miami, Florida.

AYR was formed in 2019 through a capital-pool transaction combining several state-licensed cannabis operators under a single holding company, originally called Ayr Strategies, then renamed Ayr Wellness [3]. Like other US multi-state operators (MSOs), AYR cannot list on major US stock exchanges because cannabis remains a Schedule I controlled substance under federal law [4]. Its securities trade only on Canadian and over-the-counter markets.

Ownership and corporate structure

AYR Wellness is a publicly held corporation with no parent company; its shares trade widely on the CSE and OTC markets [1][2]. The company files continuous disclosure documents on SEDAR+ (Canadian Securities Administrators) and reports to US securities regulators via its OTC listing [2].

Leadership has changed significantly since 2019. Founder Jonathan Sandelman stepped down as CEO in 2023, with the company announcing further executive transitions as part of restructuring efforts. Current officers and directors are listed in the company's most recent annual filing and should be verified through SEDAR+ or the company's investor relations page, as board composition in the cannabis sector changes frequently.

Market focus and operations

AYR operates as a vertically integrated cannabis operator, cultivating, processing, and retailing its own products through its own dispensaries in most markets. Historically the company has reported operations in Florida, Pennsylvania, Massachusetts, New Jersey, Ohio, Nevada, Illinois, and Connecticut, with retail concentrated under the Liberty Health Sciences banner in Florida and various banners elsewhere [1].

The exact state-by-state footprint and store count have changed materially over time as AYR has divested assets, closed stores, and restructured [5][6]. Readers should check AYR's most recent investor materials and state regulatory license lookups to confirm current active licenses and store locations.

AYR's product portfolio spans flower, pre-rolls, vape cartridges, concentrates, and edibles across both medical-only and adult-use markets depending on state law.

House brands

AYR markets several in-house cannabis product lines:

Important: Lazarus Naturals is a separate Oregon-based hemp and CBD company, not an AYR subsidiary or brand. If you encounter a product labeled "Lazarus," verify which company made it and which category (THC cannabis vs. hemp CBD) before assuming a connection.

This profile does not recommend any of these products. Cannabinoid content, terpene profile, cultivar genetics, and testing results vary by batch and state. The only reliable check is the certificate of analysis (COA) for the specific batch you are considering Strong evidence.

Financial status and controversies

AYR has faced material financial headwinds. Reuters, MJBizDaily, and other cannabis trade outlets have reported on the company's substantial debt load, share-price decline since its 2021 peak, asset sales, and ongoing debt-restructuring negotiations with noteholders [5][6]. In 2024 AYR announced amendments to senior secured debt and warned about going-concern risks in regulatory filings [5]. These challenges are not unique to AYR — most US MSOs have struggled with falling wholesale cannabis prices, IRS Section 280E tax burdens, and banking restrictions stemming from federal illegality [4] — but they represent material context for investors, suppliers, or employees evaluating the company.

AYR brands have won occasional state-level cannabis competition awards, but cannabis industry competitions vary widely in judging rigor and are not reliable proxies for product quality or safety Weak / limited.

This profile is not aware of any major product-safety recall uniquely tied to AYR as of the last verification date, but cannabis recalls occur regularly across the industry. Verify current recalls through your state cannabis regulator's public recall list.

AYR products are sold only inside state-legal cannabis markets where AYR or its subsidiaries hold active retail and cultivation licenses. Cannabis remains a Schedule I controlled substance under US federal law [4]. Interstate shipment of THC cannabis products is illegal regardless of state-law permissibility.

There is no legal direct-to-consumer mail order of AYR's THC products. Any website claiming to ship AYR flower, vapes, or edibles across state lines should be treated as either illegal or fraudulent.

To verify whether AYR holds current licenses in your state, consult your state cannabis regulator's public license lookup tool.

What to verify before relying on brand claims

Before treating any claim about AYR — by AYR, a retailer, or this article — as current, check:

  1. Current licensing in your state via the state cannabis regulator's public license lookup.
  2. Corporate status and filings on SEDAR+ [2] and the company's investor relations page.
  3. Certificate of analysis (COA) for the specific batch of product you are purchasing, ideally with cannabinoid and contaminant results from an ISO-accredited lab.
  4. Recent news on restructuring, executive changes, store closures, or asset sales, which have been frequent in the MSO sector [5][6].
  5. Whether "Lazarus" on a package refers to AYR's cannabis line or to the unrelated Lazarus Naturals hemp-CBD brand.

Last verified: October 2026. Brand portfolios, store counts, corporate structure, and licensing in the US cannabis industry change frequently. This profile should not be treated as a substitute for primary regulatory filings or current state license records.

Sources

  1. Reported Reuters. Ayr Wellness Inc. company profile and market data.
  2. Government Canadian Securities Administrators. Ayr Wellness Inc. issuer profile and continuous disclosure filings. SEDAR+.
  3. Reported Schaneman, B. (2021). Ayr Strategies rebrands as Ayr Wellness as it expands US footprint. MJBizDaily.
  4. Government US Drug Enforcement Administration. Drug Scheduling. Marijuana listed under Schedule I of the Controlled Substances Act.
  5. Reported MJBizDaily. Coverage of Ayr Wellness leadership changes, debt restructuring, and asset divestitures, 2023–2024.
  6. Reported Green Market Report. Coverage of Ayr Wellness financial results and restructuring, 2023–2024.

How this page was made

Generation history

Oct 31, 2026
Fact-check pass — raised 5 flags
Oct 31, 2026
Revision
Jun 8, 2026
Fact-check pass — raised 1 flag
Jun 8, 2026
Initial draft

Drafted with AI assistance and checked by a separate automated fact-check pass. Not every article has been read by a person. See how articles are made.